XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2019 $ 15,063 $ 56 $ 27,312 $ (6,956) $ (2,312) $ (4,128) $ 13,972 $ 1,091
Beginning balance, shares at Dec. 31, 2019   1,198            
Net Income (loss) 78     209     209 (131)
Other comprehensive income (loss) (379)       (391)   (391) 12
Issuance of Shares, value [1]          
Issuance of Shares, shares   4            
Stock-based compensation expense 62   62       62  
Ending balance at Jun. 30, 2020 14,824 $ 57 27,374 (6,747) (2,703) (4,128) 13,852 972
Ending balance, shares at Jun. 30, 2020   1,202            
Beginning balance at Mar. 31, 2020 14,588 $ 56 27,342 (6,887) (2,852) (4,128) 13,531 1,057
Beginning balance, shares at Mar. 31, 2020   1,201            
Net Income (loss) 53     140     140 (87)
Other comprehensive income (loss) 151       149   149 2
Issuance of Shares, value [1]            
Issuance of Shares, shares   1            
Stock-based compensation expense 32   32       32  
Ending balance at Jun. 30, 2020 14,824 $ 57 27,374 (6,747) (2,703) (4,128) 13,852 972
Ending balance, shares at Jun. 30, 2020   1,202            
Beginning balance at Dec. 31, 2020 11,061 $ 57 27,443 (10,946) (2,399) (4,128) 10,026 1,035
Beginning balance, shares at Dec. 31, 2020   1,202            
Net Income (loss) 306     284     284 21
Other comprehensive income (loss) (115)       (47)   (47) (68)
Issuance of Shares, value [1]          
Issuance of Shares, shares   6            
Stock-based compensation expense 60   60       60
Ending balance at Jun. 30, 2021 11,311 $ 57 27,503 (10,662) (2,446) (4,128) 10,324 987
Ending balance, shares at Jun. 30, 2021   1,209            
Beginning balance at Mar. 31, 2021 10,975 $ 57 27,474 (10,869) (2,534) (4,128) 10,000 975
Beginning balance, shares at Mar. 31, 2021   1,208            
Net Income (loss) 221     207     207 14
Other comprehensive income (loss) 87       88   88 (1)
Issuance of Shares, value [1]            
Issuance of Shares, shares [1]              
Stock-based compensation expense 29   29       29
Ending balance at Jun. 30, 2021 $ 11,311 $ 57 $ 27,503 $ (10,662) $ (2,446) $ (4,128) $ 10,324 $ 987
Ending balance, shares at Jun. 30, 2021   1,209            
[1] Represents an amount less than $0.5 million.